share_log

Cloud DX Reports Fiscal Third Quarter Results

Cloud DX Reports Fiscal Third Quarter Results

Cloud DX報告第三財季業績
Accesswire ·  2021/11/29 20:27

WATERLOO, ON / ACCESSWIRE / November 29, 2021 / Cloud DX (TSXV:CDX)(OTCQB:CDXFF), Cloud DX, a leading North American provider of virtual care and remote patient monitoring solutions, today reports results for the third quarter of fiscal 2021.

滑鐵盧,ON/ACCESSWIRE/2021年11月29日/Cloud DX(多倫多證券交易所股票代碼:CDX)(OTCQB:CDXFF),北美領先的虛擬醫療和遠程患者監護解決方案提供商Cloud DX今天公佈了2021財年第三季度業績。

Key Developments:

主要發展:

  • Overall revenue lower by 4%; Subscription revenue increased 22%
  • New partnerships in the quarter resulted in access to up to 27,000 patients
  • Inclusion of one-time costs attributed to the Qualifying Transaction impacted expenses;
    • 120% increase in operating expenses
    • 98% decrease in adjusted EBITDA
  • 整體收入下降4%;訂閲收入增長22%
  • 本季度新的合作伙伴關係帶來了多達27,000名患者的接觸
  • 計入可歸因於合格交易的一次性成本會影響費用;
    • 運營費用增加120%
    • 調整後的EBITDA減少98%

Third Quarter Financial Highlights

第三季度財務亮點

Year to Date Financial Highlights

今年迄今的財務亮點

Revenue

收入

In the 3 months ended September 30, 2021 subscription revenue was 19% lower. Product and professional services revenue is anticipated to be variable in the early stages of growth. Specifically, in 2020 a large Connected Health Kit deployment for an academic study generated an unusual concentration of hardware revenue that has not occurred in 2021.

在截至9月30日的3個月裏,2021年的訂閲收入下降了19%。產品和專業服務的收入預計在增長的早期階段是可變的。具體地説,在2020年,一項學術研究的大型互聯健康套件部署產生了2021年從未出現過的異常集中的硬件收入。

In the 9 months ended September 30, 2021 subscription revenue increased 22%. Similar to the three-month period, product and professional services revenue is projected to fluctuate in the early stages of growth. As noted above, in 2020 a large project-based order of Connected Health Kits had no comparison to date in 2021.

在截至9月30日的9個月中,2021年訂閲收入增長了22%。與這三個月類似,產品和專業服務收入預計將在增長的早期階段波動。如上所述,2020年基於項目的大型互聯健康套件訂單到2021年還沒有可比性。

Expenses

費用

In the 3 months ended September 30, 2021 operating expenses increased 20% predominantly caused by certain cash and non-cash expenditures associated with the Qualifying Transaction. Salaries and wages were 38% higher thanks to an additional 27 employees between September 30, 2020 and September 30, 2021. Sales, General and Administrative was 223% higher due to higher comparative advertising and promotion, insurance and subscription costs as compared to September 2020.

在截至9月30日的3個月中,2021年的運營費用增長了20%,主要是由與合格交易相關的某些現金和非現金支出造成的。在2020年9月30日至2021年9月30日期間,由於增加了27名員工,工資和工資上漲了38%。與2020年9月相比,由於比較廣告和促銷、保險和訂閲成本上升,銷售額、一般和行政費用增長了22.3%。

In the 9 months ended September 30, 2021, operating expenses increased 72% primarily driven by certain cash and non-cash expenditures associated with the RTO; Professional fees were 41% higher caused by costs attributable to this transaction; stock based compensation was higher due to the obligation to revalue employee stock-based compensation granted as previously issued stock options were cancelled prior to the RTO. Headcount increased by 29 FTEs between September 30, 2020 and September 30, 2021 causing a 74% increase in salaries and wages.

在截至2021年9月30日的9個月中,運營費用增長了72%,主要是受與RTO相關的某些現金和非現金支出的推動;專業費用因此次交易的可歸因性成本而高出41%;基於股票的薪酬較高,原因是有義務重估員工基於股票的薪酬,因為以前發行的股票期權在RTO之前被取消。從2020年9月30日到2021年9月30日,員工人數增加了29個FTE,導致工資和工資上漲了74%。

Customer Stats

客户統計數據

Cloud DX has seen access to available patients suited to its remote patient monitoring products increase as follows:

Cloud DX發現,適用於其遠程患者監護產品的可用患者數量增加如下:

About Cloud DX

關於Cloud DX

Accelerating virtual healthcare, Cloud DX is on a mission to make healthcare better for everyone. Our Connected Health TM remote patient monitoring platform is used by healthcare enterprises and care teams across North America to virtually manage chronic disease, enable aging in place, and deliver hospital-quality post-surgical care in the home. Our partners achieve better healthcare and patient outcomes, reduce the need for hospitalization or re-admission, and reduce healthcare delivery costs through more efficient use of resources. Cloud DX is the co-winner of the Qualcomm Tricorder XPRIZE, a 2021 Edison Award winner, a Fast Company "World Changing Idea" finalist, and one of "Canada's Ten Most Prominent Telehealth Providers.

加速虛擬醫療,Cloud DX肩負着讓每個人的醫療保健變得更好的使命。我們的互聯健康TM北美各地的醫療保健企業和護理團隊使用遠程患者監控平臺虛擬管理慢性病,實現就地老齡化,並在家中提供醫院質量的術後護理。我們的合作伙伴實現了更好的醫療保健和患者結果,減少了住院或重新入院的需求,並通過更有效地利用資源來降低醫療保健提供成本。Cloud DX是高通Tricorder XPRIZE的共同獲獎者,2021年愛迪生獎獲得者,Fast Company“World Change Idea”決賽入圍者,以及“加拿大十大最傑出的遠程醫療提供商”之一。

Cloud DX Investor Site

Cloud DX投資者網站

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

多倫多證券交易所創業板交易所及其監管服務提供商(該術語在多倫多證券交易所創業板政策中定義)均不對本新聞稿的充分性或準確性承擔責任。

Social Links
Twitter
Facebook
LinkedIn
Instagram

社會聯繫
推特
臉譜
LinkedIn
Instagram

For investor inquiries please contact:
Jay Bedard
Cloud DX Investor Relations
647-881-8418
jay.bedard@CloudDX.com

如有投資者查詢,請聯繫:
傑伊·貝達爾
Cloud DX投資者關係
647-881-8418
郵箱:jay.bedard@CloudDX.com

SOURCE: Cloud DX Inc.

資料來源:Cloud DX Inc.


View source version on accesswire.com:
在accesswire.com上查看源代碼版本:

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論